Literature DB >> 3549743

Alpha and beta subunits of the LFA-1 membrane molecule are involved in human monocyte-endothelial cell adhesion.

S J Mentzer, M A Crimmins, S J Burakoff, D V Faller.   

Abstract

Human monocyte adhesion to vascular endothelium is an important transitional event in mononuclear phagocyte development. The molecular mechanism involved in monocyte adhesion to endothelial cells was studied using purified human monocytes and a panel of monoclonal antibodies (MAb). The purified human monocytes were phenotypically characterized and expressed relatively low levels of HLA class II antigens. The monocytes were labeled with Indium-111 to provide high specific activity and a sensitive measure of adhesion. Using this radionuclide adhesion assay, monocytes demonstrated consistent and reproducible adhesion to a confluent monolayer of human umbilical vein-derived endothelial cells. To identify the cell surface molecules involved in human monocyte-endothelial cell adhesion, 15 MAb to 11 monocyte surface structures were used to attempt to inhibit adhesion. MAb recognizing 10 monocyte cell surface molecules did not inhibit adhesion. In contrast, MAb recognizing the alpha and beta subunits of LFA-1 (lymphocyte function-associated) significantly inhibited monocyte adhesion to endothelial cells. Monocyte adhesion was comparably inhibited by F(ab')2 and intact MAb. Significant inhibition was observed at 5 micrograms/ml of anti-LFA-1 MAb. These results indicate that the alpha and beta subunits of the LFA-1 membrane molecule are involved in human monocyte-endothelial cell adhesions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3549743     DOI: 10.1002/jcp.1041300314

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  9 in total

Review 1.  Current status review: adhesion molecules and myelomonocytic cell-endothelial interactions.

Authors:  H Rosen; S Gordon
Journal:  Br J Exp Pathol       Date:  1989-06

2.  Recognition of an endothelial determinant for CD 18-dependent human neutrophil adherence and transendothelial migration.

Authors:  C W Smith; R Rothlein; B J Hughes; M M Mariscalco; H E Rudloff; F C Schmalstieg; D C Anderson
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

3.  Neutrophil migration across a cultured intestinal epithelium. Dependence on a CD11b/CD18-mediated event and enhanced efficiency in physiological direction.

Authors:  C A Parkos; C Delp; M A Arnaout; J L Madara
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

4.  Analysis of monocyte chemoattractant protein 1-mediated lung injury using rat lung organ cultures.

Authors:  J S Warren; M L Jones; C M Flory
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

5.  Point mutations impairing cell surface expression of the common beta subunit (CD18) in a patient with leukocyte adhesion molecule (Leu-CAM) deficiency.

Authors:  M A Arnaout; N Dana; S K Gupta; D G Tenen; D M Fathallah
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

6.  Neutrophil migration across a cultured epithelial monolayer elicits a biphasic resistance response representing sequential effects on transcellular and paracellular pathways.

Authors:  C A Parkos; S P Colgan; C Delp; M A Arnaout; J L Madara
Journal:  J Cell Biol       Date:  1992-05       Impact factor: 10.539

7.  Monoclonal antibody to the murine type 3 complement receptor inhibits adhesion of myelomonocytic cells in vitro and inflammatory cell recruitment in vivo.

Authors:  H Rosen; S Gordon
Journal:  J Exp Med       Date:  1987-12-01       Impact factor: 14.307

8.  Antibody to the murine type 3 complement receptor inhibits T lymphocyte-dependent recruitment of myelomonocytic cells in vivo.

Authors:  H Rosen; G Milon; S Gordon
Journal:  J Exp Med       Date:  1989-02-01       Impact factor: 14.307

9.  ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18).

Authors:  M S Diamond; D E Staunton; A R de Fougerolles; S A Stacker; J Garcia-Aguilar; M L Hibbs; T A Springer
Journal:  J Cell Biol       Date:  1990-12       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.